Assessing the risk of alcohol-induced dose dumping from sustained-release oral dosage forms: in vitro-in silico approach
Article (Accepted Version)
MetadataShow full item record
Consumption of alcoholic beverages with sustained-release oral dosage forms may pose a risk to patients due to potential alcohol-induced dose dumping (ADD). Regulatory guidances recommend in vitro dissolution testing to identify the risk of ADD, but the question remains whether currently proposed test conditions can be considered biopredictive. The purpose of this study was to evaluate different dissolution setups to assess ADD, and the potential of combined in vitro-in silico approach to predict drug absorption after concomitant alcohol intake for hydrophilic and lipophilic sustained-release tablets containing ibuprofen or diclofenac sodium. According to the obtained results, the impact of ethanol was predominantly governed by the influence on matrix integrity, with the increase in drug solubility being less significant. Hydrophilic matrix tablets were less susceptible to ADD than lipophilic matrices, although the conclusion on formulation ethanol-vulnerability depended on the employe...d experimental conditions. In silico predictions indicated that the observed changes in drug dissolution would not result in plasma concentrations beyond therapeutic window, but sustained-release characteristics of the formulations might be lost. Overall, the study demonstrated that in vitro-in silico approach may provide insight into the effect of ADD on drug clinical performance, and serve as a tool for ADD risk assessment.
Keywords:Alcohol-induced dose dumping / sustained release / dissolution / physiologically based modeling / hydrophilic matrix tablets / lipophilic matrix tablets
Source:Pharmaceutical Development and Technology, 2018, 23, 9, 921-932
- Taylor & Francis Ltd, Abingdon
- This is peer-reviewed version of the following article: Cvijić, S.; Aleksić, I.; Ibrić, S.; Parojčić, J. Assessing the Risk of Alcohol-Induced Dose Dumping from Sustained-Release Oral Dosage Forms: In Vitro–in Silico Approach. Pharm. Dev. Technol. 2018, 23 (9), 921–932. https://doi.org/10.1080/10837450.2017.1392973